Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 545)
Posted On: 01/30/2020 3:01:12 PM
Post# of 72447
Avatar
Posted By: TreeFrog
Here is the principal investigator of the study. Sounds like we couldn't get a better guy.

Professor Howard Stevens is Chairman of BDD Pharma and Emeritus Professor of Drug Delivery at the University of Strathclyde. Prior to joining the University in 1995, he worked 25 years in the Pharmaceutical Industry, holding a number of high level development positions in the UK and Europe [Boots Company, ER Squibb, Synthélabo (Paris), Scherer DDS].
His research interests are in the development of oral controlled release preparations and in understanding in-vivo performance in man using gamma scintigraphy and pharmacokinetics. He has published widely and is named inventor on over 20 drug delivery patents.
He is a Fellow of the Royal Pharmaceutical Society of Great Britain and the Royal Society of Chemistry. He has served on MHRA regulatory committees and as Chairman of the Academy of Pharmaceutical Sciences in 2001. He received the Nexxus Life-Time Achievement Award (2011) in recognition of his contribution to the Life Sciences business sector in Scotland.













(5)
(1)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site